Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo.
Fluconazole (UK 49,858), a new orally administered bis-triazole, was compared with ketoconazole for activity in synthetic broth dilution susceptibility tests against Candida albicans and also in treatment of experimental systemic candidal infections in rats. In vitro studies indicated that fluconazo...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1986
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180572/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3022641/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.30.3.418 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|